SEC Form D · filed June 5, 2017
Deciphera Pharmaceuticals, LLC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Oliver L. Rosen, M.D · Waltham, MAExecThomas L. Kelly · Waltham, MAExecJohn A. Martin · Waltham, MADirectorDaniel L. Flynn, Ph.D · Waltham, MAExecDennis A. Walsh · Waltham, MADirectorJames A. Bristol, Ph.D · Waltham, MADirectorChristopher J. Morl · Waltham, MAExecLiam A. Ratcliffe, M.D., Ph.D · Waltham, MADirectorEdward J. Benz, Jr · Waltham, MADirectorMichael A. Ross · Herndon, VADirectorPatricia L. Allen · Waltham, MADirectorMichael D. Taylor, Ph.D · Waltham, MAExec · DirectorEdward J. Benz, Jr · Waltham, MADirectorMichael A. Ross · Herndon, VADirectorOliver L. Rosen, M.D · Waltham, MAExecThomas L. Kelly · Waltham, MAExecPatricia L. Allen · Waltham, MADirectorJohn A. Martin · Waltham, MADirectorDaniel L. Flynn, Ph.D · Waltham, MAExecDennis A. Walsh · Waltham, MADirectorJames A. Bristol, Ph.D · Waltham, MADirectorChristopher J. Morl · Waltham, MAExecMichael D. Taylor, Ph.D · Waltham, MAExec · DirectorLiam A. Ratcliffe, M.D., Ph.D · Waltham, MADirectorEdward J. Benz, Jr · Greenwich, CTDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗